CERBA   Report issue

For profit Phase 2 Phase 3
Founded: Saint-ouen-l'aumone France (1967)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

Key: CERBA (0) Acquired (2)

gemcitabine (gemzar) (1 trial)

gv 1001 (1 trial)

Drugs in Phase 2 Trials (2)

Key: CERBA (0) Acquired (2)

bgp-15 (1 trial)

tetracycline (tetrex) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 4